Abstract

In an attempt to determine the proper range of long-term anticoagulation, a group of patients under treatment were divided into three treatment groups, intensive, moderate, and control. While there was not a significant difference in the mortality in these 178 patients who were followed for two years, there was a statistically significant reduced number of thromboembolic complications both in the intensive and moderate treatment groups compared to the control group. Since there were more hemorrhages in the intensively treated group, the moderately treated patients fared the best overall. The Quick test results averaged 15 to 20 seconds; thrombotest, 8% to 20%; prothrombinproconvertin test, 20% to 50%; and factor II (prothrombin), 30% to 50%. These ranges are more moderate than the generally recommended ones.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.